Sanofi’s Eloxatin found effective in colorectal cancer study
The study (Eortc 40983 Intergroup study) is also referred to as the EPOC trial. Among the 342 eligible patients treated in the EPOC study, perioperative 5-fluorouracil/leucovorin (FOLFOX4 chemotherapy)
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.